Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer-Reference-Cited by-同舟云学术

Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer

Published:2017-03-21 Issue:5 Volume:37 Page:649-654
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Bozkaya Yakup¹,Doğan Mutlu¹,Umut Erdem Gökmen¹,Tulunay Gökhan²,Uncu Hikmet³,Arık Zafer⁴,Demirci Umut⁵,Yazıcı Ozan¹,Zengin Nurullah¹

Affiliation:

1. Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey;

2. Department of Gynecologic Oncology, Etlik Zübeyde Hanım Women’s Health Education and Research Hospital, Ankara, Turkey;

3. Department of Gynecologic Oncology, Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey;

4. Department of Medical Oncology, Zekai Tahir Burak Women’s Health Education And Research Hospital, Ankara, Turkey;

5. Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Education and Research Hospital, Ankara, Turkey

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2017.1290056

Reference30 articles.

1. Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

2. Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

3. Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy

4. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

5. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Available from: http://globocan.iarc.fr.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Recipe for Successful Metastasis: Transition and Migratory Modes of Ovarian Cancer Cells;Cancers;2024-02-15

2. Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer;Journal of Gynecologic Oncology;2024

3. Elevated Levels of Lamin A Promote HR and NHEJ-Mediated Repair Mechanisms in High-Grade Ovarian Serous Carcinoma Cell Line;Cells;2023-02-27

4. Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer;Medical Oncology;2022-09-29

5. Elevated levels of lamin A promote HR and NHEJ-mediated repair mechanisms in etoposide-treated ovarian cancer cells;2022-09-03